Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 16/20 | 0.65 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.51 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.51 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.51 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4113424 | 1.00 | HRH3 (0.65) | HRH3CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL4108977 | 0.88 | CHRNB2 (0.61) | HRH3CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL4920608 | 0.79 | HRH3 (1.00) | HRH3KCNH2 | |
| SCHEMBL4920616 | 0.79 | HRH3 (1.00) | HRH3KCNH2 | |
| SCHEMBL2410032 | 0.79 | HRH3 (1.00) | HRH3KCNH2 | |
| SCHEMBL2412379 | 0.75 | HRH3 (1.00) | HRH3KCNH2 | |
| SCHEMBL4113397 | 0.75 | GPR119 (0.47) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL4113401 | 0.75 | GPR119 (0.47) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL3062935 | 0.74 | HRH3 (0.60) | HRH3CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL24528539 | 0.73 | CHRNB2 (0.49) | CHRNB2CHRNA4CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2231672-A1 | BIARYL SUBSTITUTED DIAZABICYCLOALKANE DERIVATIVES | Abbott Laboratories (US) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009067586-A1 | BIARYL SUBSTITUTED DIAZABICYCLOALKANE DERIVATIVES | ABBOTT LABORATORIES (US) | 2009-05-28 | — | — | WO | disclosed |